Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis
Oncogene (2005) - Comments
pubmed: 16103877  doi: 10.1038/sj.onc.1208954  issn: 0950-9232  issn: 1476-5594 

Mario I Vega, Sara Huerta-Yepez, Ali R Jazirehi, Hermes Garban, Benjamin Bonavida